https://nsc113928agonist.com/n....on-oncologic-uses-of
Contrary to TNC, liver-attenuation and LAI were not higher in amiodarone clients in VNC-Chest and in VNC-Abdomen. To verify these initial outcomes, a phantom scan had been carried out and one more patient cohort included, both confirming that VNC is viable of accurately subtracting iodine of hepatic amiodarone-deposits. This may help to monitor liver-attenuation more precisely and thus detect liver steatosis as a sign of liver harm earlier as well as to confirm amiodarone accumulation into the liver.Be
Beğen
Yorum Yap
Paylaş
